Mary Hanson, MD
Assistant Professor-Clinical

- Phone:
- 614-685-5399
- E-mail:
- Email Dr. Hanson
- Office Location:
- M366 Starling Loving Hall
- 320 W. 10th Ave.
- Columbus, OH 43210
Biosketch
Mary Hanson, MD, is an Assistant Professor in the Clinical Pathology Branch. She earned her MD from the University of South Dakota School of Medicine in 2021, and completed her Anatomic and Clinical Pathology residency at Creighton University in 2025. Dr. Hanson completed a fellowship in Transfusion Medicine at the University of Minnesota in 2026.
Board Certifications
Anatomic and Clinical Pathology, American Board of Pathology
Academic and Medical Appointments
2026-Present Assistant Professor, Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH
Education and Training
2025-2026 Fellowship, Transfusion Medicine, University of Minnesota, Minneapolis, MN
2023-2025 Residency, Pathology, Creighton University, Omaha, NE
2021-2022 Residency, Pathology, Brookwood Baptist Health, Birmingham, AL
2017-2021 MD, University of South Dakota, Sioux Falls, SD
Selected Publications
- Hanson M and Hebel E. Medical laboratory training in the United States. Transfusion and Apheresis Science. 2026. [In print].
- Hanson M. Techniques of transfusion. In: McCullough J, editor. Transfusion Medicine 6th Ed, West Sussex: John Wiley and Sons. 2026. [In print].
- Le P, Gonzalez M, Hanson M, et al. R485K polymorphism of the factor V gene: Breakdown of hyperocoagulable clinical phenotypes and race prevalence. 2026. [Not yet published].
- Hanson M. Demystifying the red cell exchange. New York Blood Center Enterprises. 2026. NYBCe Lab Week, recorded. [Oral presentation].
- Hanson M, Le P, Eladely A. Massive transfusion protocol: Quality improvement. 2025. Creighton University, Omaha, NE. [Oral presention].
- Hanson M. Therapeutic plasma exchange and IVIG treatments to improve viability of a K+ sensitized pregnancy. Cureus 2024; 16(10): e72254.
- Pazhayattil J, Hanson M, Monika F, Salibindla D, Cavalieri S. Atypical presentation of Vibrio cholerae: Fulminant necrotizing fasciitis leading to mortality. 2024. CAP 24, Las Vegas, NV. [Poster].
- Le P, Hanson M, et al. Difference In clinical presentation for individuals with R485K polymorphism compared to those with factor V Leiden mutation: A single institution study. 2024. CAP24, Las Vegas, NV, USA. [Poster Presentation].
- Hanson M, Chaussee MS. Recurrent streptococcal cellulitis: a case report and review. South Dakota Medicine 2020; 73(7), 318-322.
- Herrera, AL, Van Hove, C, Hanson, M, Dale, JB, Tweten, RK, Huber, VC, Diel, D, and Chausee, MS. Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection. PLoS ONE 2020; 15 (6):e0235139.
